Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Nehal N. Mehta received his MSCE with a focus in genetic epidemiology. He is currently the Director of the Inflammatory Risk Clinic within Preventive Cardiology. He has clinical and research interests in moving epidemiological observations into translational studies in humans studying how inflammation affects insulin resistance, the metabolic syndrome and atherosclerosis. Collaborating with Dr. Joel M. Gelfand, MD, MSCE, he is currently focused on cardiovascular risk stratification of patients with psoriasis, and mechanisms of the skin/vascular disease link. His long term goal is to improve risk stratification and risk prediction for heart disease in novel populations. He is the recipient of an NIH career-development award which examines the role of an inflammatory chemokine in a population-based study, then studying the chemokine in cells and tissues involved in atherosclerosis to dissect mechanism of disease. This project is under the mentored guidance of Drs. Muredach P. Reilly MBBCh, MSCE and Daniel J. Rader, MD. Dr. Mehta is board certified in internal medicine, nuclear cardiology, echocardiography and cardiovascular diseases.